These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19546611)

  • 1. Castleman disease: an update on classification and the spectrum of associated lesions.
    Cronin DM; Warnke RA
    Adv Anat Pathol; 2009 Jul; 16(4):236-46. PubMed ID: 19546611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Castleman's disease.
    Palestro G; Turrini F; Pagano M; Chiusa L
    Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Castleman disease in an HIV-infected patient with Kaposi sarcoma.
    Saif MW
    AIDS Read; 2001 Nov; 11(11):572-6. PubMed ID: 11789020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease.
    Vasudev Rao T; Alkindi S; Pathare AV
    Pathol Res Pract; 2007; 203(6):479-84. PubMed ID: 17418501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human herpesvirus 8 infections in patients with immunodeficiencies.
    Laurent C; Meggetto F; Brousset P
    Hum Pathol; 2008 Jul; 39(7):983-93. PubMed ID: 18570975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)-latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T-cell response.
    El-Daly H; Bower M; Naresh KN
    Eur J Haematol; 2010 Feb; 84(2):133-6. PubMed ID: 19799625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaline vascular Castleman's disease: a case report and brief review of the literature.
    van den Berge M; Pauwels P; Jakimowicz JJ; Creemers GJ
    Neth J Med; 2002 Dec; 60(11):444-7. PubMed ID: 12685494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Castleman disease: the great mimic.
    Bonekamp D; Horton KM; Hruban RH; Fishman EK
    Radiographics; 2011 Oct; 31(6):1793-807. PubMed ID: 21997995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
    Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
    Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of bone marrow in human herpes virus-8 (HHV8)-associated multicentric Castleman disease.
    Bacon CM; Miller RF; Noursadeghi M; McNamara C; Du MQ; Dogan A
    Br J Haematol; 2004 Dec; 127(5):585-91. PubMed ID: 15566362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
    Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
    Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castleman's disease. Update on pathogenesis.
    Al-Maghrabi JA
    Saudi Med J; 2011 May; 32(5):451-8. PubMed ID: 21556463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital involvement in Castleman disease.
    Venizelos I; Papathomas TG; Papathanasiou M; Cheva A; Garypidou V; Coupland S
    Surv Ophthalmol; 2010; 55(3):247-55. PubMed ID: 20070998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection.
    Menke DM; Chadbum A; Cesarman E; Green E; Berenson J; Said J; Tiemann M; Parwaresch R; Thome SD
    Am J Clin Pathol; 2002 Feb; 117(2):268-75. PubMed ID: 11863223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma.
    Naresh KN; Rice AJ; Bower M
    Am J Surg Pathol; 2008 Jul; 32(7):1006-12. PubMed ID: 18469709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow findings in multicentric Castleman disease in HIV-negative patients.
    Kreft A; Weber A; Springer E; Hess G; Kirkpatrick CJ
    Am J Surg Pathol; 2007 Mar; 31(3):398-402. PubMed ID: 17325481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
    Ohgami RS; Zhao S; Ohgami JK; Leavitt MO; Zehnder JL; West RB; Arber DA; Natkunam Y; Warnke RA
    Am J Surg Pathol; 2012 Nov; 36(11):1619-28. PubMed ID: 23060347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Hodgkin disease tumor in the neck of a patient who previously had undergone complete excision of a hyaline-vascular Castleman disease neck mass.
    Unsal Tuna EE; Ozbek C; Arda N; Ilkdogan E; Dere H; Ozdem C
    Ear Nose Throat J; 2010 Apr; 89(4):E20-3. PubMed ID: 20397132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis.
    Higashi Y; Kanekura T; Sakamoto R; Mochitomi Y; Kanzaki T
    Dermatology; 2007; 214(2):170-3. PubMed ID: 17341868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.